Related Experiment Video
Updated: May 1, 2026
07:16
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
14.1K
Methods for recombinant expression and functional characterization of human cannabinoid receptor CB2
1National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, Bethesda, MD 20892, USA.
Computational and Structural Biotechnology Journal
|April 2, 2014
Summary
Researchers developed a method to produce large amounts of active Cannabinoid receptor 2 (CB2) for drug development. This involves expressing, purifying, and stabilizing the receptor for detailed structural and functional studies.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Cannabinoid receptor 2 (CB2) is a G protein-coupled receptor (GPCR) crucial for immune regulation, inflammation, and pain.
- Understanding CB2 structure and function is vital for developing targeted pharmaceuticals.
Purpose of the Study:
- To review a methodology for producing milligram quantities of functional CB2 receptor.
- To enable detailed biochemical and biophysical studies of CB2.
Main Methods:
- Recombinant expression of CB2 in E. coli as a fusion protein.
- Stabilization using high-affinity ligands and cholesterol derivatives in detergent micelles.
- Purification via tandem affinity chromatography and reconstitution into lipid bilayers.
Main Results:
- Successful production of functionally active, purified recombinant CB2.
- The methodology yields multi-milligram quantities suitable for advanced studies.
- Reconstituted receptor is amenable to NMR spectroscopy and other biophysical techniques.
Conclusions:
- The described biotechnological approach provides a robust platform for CB2 research.
- This facilitates structural and functional characterization for rational drug design.
- Enables deeper understanding of the endocannabinoid system's role in physiological processes.
